GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Novacyt SA (LSE:NCYT) » Definitions » Other Stockholders Equity

Novacyt (LSE:NCYT) Other Stockholders Equity : £3.55 Mil (As of Jun. 2024)


View and export this data going back to 2017. Start your Free Trial

What is Novacyt Other Stockholders Equity?

Novacyt's Other Stockholders Equity for the quarter that ended in Jun. 2024 was £3.55 Mil.

Novacyt's quarterly Other Stockholders Equity increased from Jun. 2023 (£-0.39 Mil) to Dec. 2023 (£2.75 Mil) and increased from Dec. 2023 (£2.75 Mil) to Jun. 2024 (£3.55 Mil).

Novacyt's annual Other Stockholders Equity declined from Dec. 2021 (£-0.02 Mil) to Dec. 2022 (£-0.86 Mil) but then increased from Dec. 2022 (£-0.86 Mil) to Dec. 2023 (£2.75 Mil).

Novacyt Other Stockholders Equity Historical Data

The historical data trend for Novacyt's Other Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Novacyt Other Stockholders Equity Chart

Novacyt Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Other Stockholders Equity
Get a 7-Day Free Trial Premium Member Only Premium Member Only -1.59 -0.88 -0.02 -0.86 2.75

Novacyt Semi-Annual Data
Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24
Other Stockholders Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.45 -0.86 -0.39 2.75 3.55

Novacyt Other Stockholders Equity Calculation

Other Stockholders Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. GuruFocus lists following items in "Total Stockholders Equity" section:
Common Stock
Preferred Stock
Retained Earnings
Accumulated other comprehensive income (loss)
Additional Paid-In Capital
Treasury Stock
Other Stockholders Equity

Novacyt Other Stockholders Equity Related Terms

Thank you for viewing the detailed overview of Novacyt's Other Stockholders Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Novacyt Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Novacyt SA (LSE:NCYT) » Definitions » Other Stockholders Equity
Comparable Companies
XPAR:ALBIO XPAR:ALCAR XPAR:ALMDT XPAR:ALIKO XPAR:ALDMS XPAR:AFME XPAR:ALIMP XPAR:ALMKT XPAR:ALBLU XPAR:ALTHE ABT BSX SYK MDT XTER:SHL EW SZSE:300760 DXCM XAMS:PHIA ZBH
Traded in Other Exchanges
NVYTF:USA ALNOV:France NYZ:Germany
Address
131 Boulevard Carnot, Le Vesinet, FRA, 78110
Website
https://www.novacyt.com
Novacyt SA is engaged in developing and selling diagnostic products for cancer and infectious diseases. The company operates its business through the following business segments: Primer Design, IT-IS International, Lab21 Products, Corporate, Yourgene Health and Intercompany eliminations. Majority of the revenue is generated from Yourgene Health segment.

Novacyt Headlines

No Headlines